Gold Investment Management Ltd. acquired a new position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 69,664 shares of the company’s stock, valued at approximately $994,000. A number of other large investors […]